China CT Scan Market Analysis

China CT Scan Market Executive Summary

China CT Scan Market was valued at $370.59 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $693.71 Mn by 2030.

A CT scan, or computed tomography scan, is a sophisticated imaging procedure that uses X-rays to produce detailed cross-sectional images of the body. Unlike traditional X-rays, CT scans capture multiple views from various angles, which a computer then processes into a three-dimensional representation of internal structures such as organs, bones, and soft tissues. Before the scan, patients may prepare by wearing a gown and removing metal objects. Depending on the type of scan, they might need to ingest a contrast material to enhance the visibility of specific tissues. During the scan, patients lie on a table that moves through a donut-shaped scanner while X-ray images are taken. Afterward, a radiologist interprets the images to diagnose conditions like cancer, heart disease, bone fractures, internal bleeding, and injuries. While CT scans offer detailed diagnostic capabilities, they involve radiation exposure and can be costly, though advancements have minimized risks and enhanced safety. Other imaging options like X-rays, ultrasound, and MRI scans are considered based on specific medical needs and radiation concerns.

In China, the prevalence of chronic obstructive pulmonary disease (COPD) ranges from 1.20% to 8.87%, averaging 5.87%, with higher rates in rural areas. The number of COPD cases is projected to rise from 25.7 Mn in 2010 to 55.2 Mn by 2030. Hepatic steatosis is also prevalent, affecting 46.3% of women and 58.9% of men, comparable to rates in the U.S. Furthermore, a cross-sectional study of 38,093 adults in 10 major Chinese cities found a 10.1% crude prevalence of chronic kidney disease (CKD), using criteria including decreased glomerular filtration rate, albuminuria, and kidney structural abnormalities detected by ultrasound, which identified an additional 11.1% of CKD cases.

The market therefore is driven by significant factors like the rising burden of chronic diseases, technological advancements, and the growing geriatric population. However, the high cost of CT scanners, radiation exposure concerns, and skilled workforce shortage restrict the growth and potential of the market.

A prominent player in this field is GE Healthcare, which launched a new refurbishing unit in Bangladesh for A1-Sure Ultrasound Systems, aiming to enhance accessibility to affordable ultrasound technology in developing regions, and Siemens Healthineers partnered with Microsoft to utilize Azure cloud services for AI-powered medical imaging solutions, aimed at advancing healthcare delivery with secure and scalable cloud computing. Other contributors include Canon Medical Systems, and NeuroLogica Corp. among others.

Market Dynamics

Market Growth Drivers

Rising Burden of Chronic Diseases: China faces a significant burden of chronic diseases, including cancer. According to the Chinese Medical Journal (March 2022), there were approximately 4.82 Mn cancer cases in 2022. The crucial role of CT scans in early detection and treatment planning is driving market growth.

Technological Advancements: The CT scan market in China is boosted by continuous technological advancements. For example, researchers in Chengdu have developed a compact, mobile CT scanner with minimal radiation and low energy consumption, enhancing capabilities and demand.

Growing Geriatric Population: China's aging population is a major driver of CT scan demand. As of 2019, there were 254 Mn people aged 60 or above, projected to reach 402 Mn by 2040. This increase in the elderly population leads to higher healthcare needs and greater demand for diagnostic scans.

Market Restraints

High Cost of CT Scanners: The high cost of purchasing and maintaining CT scanners can limit affordability for smaller hospitals and clinics, hindering broader market penetration.

Radiation Exposure Concerns: While CT scans provide valuable diagnostic benefits, concerns about radiation exposure, especially with repeated scans, may lead patients to seek alternative imaging methods.

Skilled Workforce Shortage: The efficient utilization of CT scanners requires specialized training, and a shortage of qualified radiologists and technicians in some regions can impede market growth.

Regulatory Landscape and Reimbursement Scenario

The regulatory environment for the CT scan market in China is characterized by stringent oversight from the National Medical Products Administration (NMPA). The NMPA requires all medical devices, including CT scanners, to undergo a rigorous approval process that includes clinical trials and safety evaluations. This regulatory framework ensures the safety and efficacy of CT scanners but can also create barriers for foreign manufacturers trying to enter the Chinese market. Additionally, the registration process for imported medical devices can be lengthy and complex, potentially delaying the introduction of new technologies.

On the reimbursement front, the Chinese government has been making efforts to improve healthcare access and affordability, which includes expanding insurance coverage for diagnostic procedures like CT scans. Public health insurance schemes, such as the Urban Employee Basic Medical Insurance (UEBMI) and the New Rural Cooperative Medical Scheme (NRCMS), cover a significant portion of the population and include provisions for CT scan reimbursement. However, the level of reimbursement can vary significantly depending on the region and the specific insurance plan. While these efforts are increasing access to CT scans, out-of-pocket expenses can still be substantial for many patients, particularly in rural areas where insurance coverage may be less comprehensive.

Competitive Landscape

Key Players

Here are some of the major key players in the China CT Scan Market:

• GE HealthCare
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Canon Medical Systems
• NeuroLogica Corp.
• Shanghai United Imaging Healthcare Co., Ltd.
• Fujifilm Holdings Corporation
• Shenzhen Anke High-tech Co., Ltd.
• Koning Health
• Carestream Dental LLC.